Skip to main content

Table 4 Change in headache outcomes and behavioural parameters at follow-up (3–6 months, n = 66–69)

From: Pain-related avoidance and endurance behaviour in migraine: an observational study

  Baseline Follow-up
(3–6 months)
Statistics
Headache days per month 12.9 ± 7.9 8.5 ± 7.7 Z = − 5.7, p < 0.001
Headache intensity [0–10] 6.5 ± 1.6 6.0 ± 1.7 Z = − 2.6, p = 0.009
Days with intake of acute migraine medication per month 8.5 ± 5.3 6.3 ± 4.7 Z = − 3.9, p < 0.001
MIDAS score [0–270] 42.2 ± 39.8 30.9 ± 39.5 Z = − 3.0, p = 0.003
PDI [0–10] 4.5 ± 2.2 3.9 ± 2.4 Z = - 2.0, p = 0.048
HADS-Depression 4.9 ± 3.4 4.8 ± 3.3 Z = − 0.5, p = 0.65
HADS-Anxiety 7.5 ± 3.9 7.2 ± 3.8 Z = - 0.5, p = 0.64
AEQ-ASAS (Avoidance of social activities) [0–6] 2.8 ± 1.2 2.9 ± 1.2 Z = − 0.9, p = 0.36
AEQ-APAS (Avoidance of physical activities) [0–6] 3.6 ± 1.0 3.7 ± 1.0 Z = − 1.6, p = 0.12
AEQ-BES (Behavioural endurance) [0–6] 2.9 ± 0.8 2.9 ± 0.9 Z = − 0.3, p = 0.73
AEQ-HDS (Humor/distraction) [0–6] 2.2 ± 0.9 2.2 ± 1.0 Z = − 0.7. p = 0.51
AEQ-PPS (Pain persistence) [0–6] 3.4 ± 0.9 3.4 ± 0.9 Z = − 0.7, p = 0.51
  1. Values are given as mean and standard deviation. MIDAS, Migraine Disability Assessment Scale; PDI Pain Disability Index, HADS Hospital Anxiety and Depression scale. AEQ Avoidance Endurance Questionnaire. Statistics are results of Wilcoxon’s test. Significant results are marked in bold
\